Autoimmune autonomic ganglionopathy: an update on diagnosis and treatment

References

• Vernino S, Adamski J, Kryzer TJ, et al. Neuronal nicotinic ACh receptor antibody in subacute autonomic neuropathy and cancer-related syndromes. Neurology. 1998;50:1806–1813.
   PubMed Web of Science ®Google Scholar
• Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med. 2000;343:847–855.
   PubMed Web of Science ®Google Scholar
• Vernino S, Hopkins S, Wang Z. Autonomic ganglia, acetylcholine receptor antibodies, and autoimmune ganglionopathy. Auton Neurosci. 2009;146:3–7.
   PubMed Web of Science ®Google Scholar
• Young RR, Asbury AK, Adams RD, et al. Pure pan-dysautonomia with recovery. Trans Am Neurol Assoc. 1969;94:355–357.
   PubMedGoogle Scholar
• Young RR, Asbury AK, Corbett JL, et al. Pure pan-dysautonomia with recovery. Description and discussion of diagnostic criteria. Brain. 1975;98:613–636.
   PubMed Web of Science ®Google Scholar
• Appenzeller O, Kornfeld M. Acute pandysautonomia. Clinical and morphologic study. Arch Neurol. 1973;29:334–339.
   PubMedGoogle Scholar
• Okada F, Yamashita I, Suwa N. Two cases of acute pandysautonomia. Arch Neurol. 1975;32:146–151.
   PubMedGoogle Scholar
• Colan RV, Snead OC 3rd, Oh SJ, et al. Acute autonomic and sensory neuropathy. Ann Neurol. 1980;8:441–444.
   PubMed Web of Science ®Google Scholar
• Koike H, Atsuta N, Adachi H, et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain. 2010;133:2881–2896.
   PubMed Web of Science ®Google Scholar
• Koike H, Watanabe H, Sobue G. The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. J Neurol Neurosurg Psychiatry. 2013;84:98–106.
   PubMed Web of Science ®Google Scholar
• Fagius J, Westerberg CE, Olsson Y. Acute pandysautonomia and severe sensory deficit with poor recovery. A clinical, neurophysiological and pathological case study. J Neurol Neurosurg Psychiatry. 1983;46:725–733.
   PubMed Web of Science ®Google Scholar
• Hainfellner JA, Kristoferitsch W, Lassmann H, et al. T-cell-mediated ganglionitis associated with acute sensory neuronopathy. Ann Neurol. 1996;39:543–547.
   PubMed Web of Science ®Google Scholar
• Nakane S, Mukaino A, Maeda Y, et al. Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey. J Neurol Neurosurg Psychiatry. 2017;88:367–368.
   PubMed Web of Science ®Google Scholar
• Albuquerque EX, Pereira EF, Alkondon M, et al. Mammalian nicotinic acetylcholine receptors: from structure to function. Physiol Rev. 2009;89:73–120.
   PubMed Web of Science ®Google Scholar
• Corringer PJ, Le Novère N, Changeux JP. Nicotinic receptors at the amino acid level. Annu Rev Pharmacol Toxicol. 2000;40:431–458.
   PubMed Web of Science ®Google Scholar
• Dani JA, Bertrand D. Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol. 2007;47:699–729.
   PubMed Web of Science ®Google Scholar
• Hendricksen LM, Guildford MJ, Tapper AR. Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. Front Psychiatry. 2013;4:29.
   PubMedGoogle Scholar
• Vernino S, Sandroni P, Singer W, et al. Invited article: autonomic ganglia: target and novel therapeutic tool. Neurology. 2008;70:1926–1932.
   PubMed Web of Science ®Google Scholar
• Xu W, Gelber S, Orr-Urtreger A, et al. Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor. Proc Natl Acad Sci USA. 1999;96:5746–5751.
   PubMed Web of Science ®Google Scholar
• Skok MV, Voitenko LP, Voitenko SV, et al. Alpha subunit composition of nicotinic acetylcholine receptors in the rat autonomic ganglia neurons as determined with subunit-specific anti-alpha (181–192) peptide antibodies. Neuroscience. 1999;93:1427–1436.
   PubMed Web of Science ®Google Scholar
• Karlin A. Emerging structure of the nicotinic acetylcholine receptors. Nat Rev Neurosci. 2002;3:102–114.
   PubMed Web of Science ®Google Scholar
• Wang Z, Low PA, Jordan J, et al. Autoimmune autonomic ganglionopathy: IgG effects on ganglionic acetylcholine receptor current. Neurology. 2007;68:1917–1921.
   PubMed Web of Science ®Google Scholar
• Kobayashi S, Yokoyama S, Maruta T, et al. Autoantibody-induced internalization of nicotinic acetylcholine receptor α3 subunit exogenously expressed in human embryonic kidney cells. J Neuroimmunol. 2013;257:102–106.
   PubMed Web of Science ®Google Scholar
• Lennon VA, Ermilov LG, Szurszewski JH, et al. Immunization with neuronal nicotinic acetylcholine receptor induces neurological autoimmune disease. J Clin Invest. 2003;111:907–913.
   PubMed Web of Science ®Google Scholar
• Hayashi M, Ishii Y. A Japanese case of autoimmune autonomic ganglionopathy (AAG) and a review of AAG cases in Japan. Auton Neurosci. 2009;146:26–28.
   PubMed Web of Science ®Google Scholar
• Nakane S, Higuchi O, Koga M, et al. Clinical features of autoimmune autonomic ganglionopathy and the detection of subunit-specific autoantibodies to the ganglionic acetylcholine receptor in Japanese patients. PLoS One. 2015;10:e0118312.
   PubMed Web of Science ®Google Scholar
• Burbelo PD, Ching KH, Klimavicz CM, et al. Antibody profiling by Luciferase Immunoprecipitation Systems (LIPS). J Vis Exp. 2009;32:pii:1549.
   Google Scholar
• Burbelo PD, Issa AT, Ching KH, et al. Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol. 2010;17:904–909.
   PubMed Web of Science ®Google Scholar
• Higuchi O, Hamuro J, Motomura M, et al. Autoantibodies to low-density lipoprotein receptor-related protein 4 in myasthenia gravis. Ann Neurol. 2011;69:418–422.
   PubMed Web of Science ®Google Scholar
• Ustinova J, Zusinaite E, Utt M, et al. Development of a luciferase-based system for the detection of ZnT8 autoantibodies. J Immunol Methods. 2014;405:67–73.
   PubMed Web of Science ®Google Scholar
• Verhaegent M, Christopoulos TK. Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. Anal Chem. 2002;74:4378–4385.
   PubMed Web of Science ®Google Scholar
• Tannous BA, Kim DE, Fernandez JL, et al. Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. Mol Ther. 2005;11:435–443.
   PubMed Web of Science ®Google Scholar
• Kim SB, Suzuki H, Sato M, et al. Superluminescent variants of marine luciferases for bioassays. Anal Chem. 2011;3:8732–8740.
   Google Scholar
• Mukaino A, Nakane S, Higuchi O, et al. Insights from the ganglionic acetylcholine receptor autoantibodies in patients with Sjögren’s syndrome. Mod Rheumatol. 2016;26:708–715.
   PubMed Web of Science ®Google Scholar
• Maeda Y, Migita K, Higuchi O, et al. Association between anti-ganglionic nicotinic acetylcholine receptor (gAChR) antibodies and HLA-DRB1 alleles in the Japanese population. PLOS One. 2016;11:e0146048.
   PubMed Web of Science ®Google Scholar
• Ching KH, Burbelo PD, Kimball RM, et al. Recombinant expression of the AChR-alpha1 subunit for the detection of conformation-dependent epitopes in Myasthenia gravis. Neuromuscul Disord. 2011;21:204–213.
   PubMed Web of Science ®Google Scholar
• Conti-Fine BM, Milani M, Kaminski HJ. Myasthenia gravis: past, present, and future. J Clin Invest. 2007;116:2843–2854.
   Web of Science ®Google Scholar
• Baker SK, Morillo C, Vernino S. Autoimmune autonomic ganglionopathy with late-onset encephalopathy. Auton Neurosci. 2009;146:29–32.
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Centi J, Vernino S, et al. Autoimmune autonomic ganglionopathy with reversible cognitive impairment. Arch Neurol. 2012;69:461–466.
   PubMedGoogle Scholar
• Okada F. Psychiatric aspects of acute pandysautonomia. Eur Arch Psychiatry Clin Neurosci. 1990;240:134–135.
   PubMed Web of Science ®Google Scholar
• Fukuda M, Morimoto T, Matsuda H, et al. A case of acute idiopathic pandysautonomia with SIADH. No To Hattatsu. 1995;27:41–46.
   PubMedGoogle Scholar
• Matsui M, Akiguchi I, Kameyama M. Case of acute polyradiculoneuropathy with various autonomic symptoms and amenorrhea-galactorrhea syndrome. Rinsho Shinkeigaku. 1983;23:526–530.
   PubMedGoogle Scholar
• Inoue Y, Motegi T, Yuasa T, et al. Acute autonomic and sensory neuropathy associated with galactorrhea-amenorrhea syndrome and intractable anorexia. Rinsho Shinkeigaku. 1989;29:1265–1271.
   PubMedGoogle Scholar
• Philip NS, Carpenter LL, Tyrka AR, et al. Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl). 2010;212:1–12.
   PubMed Web of Science ®Google Scholar
• Reuter M, Markett S, Melchers M, et al. Interaction of the cholinergic system and the hypothalamic-pituitary-adrenal axis as a risk factor for depression: evidence from a genetic association study. Neuroreport. 2012;23:717–720.
   PubMed Web of Science ®Google Scholar
• McKeon A, Lennon VA, Lachance D, et al. Ganglionic acetylcholine receptor autoantibody: oncological, neurological, and serological accompaniments. Arch Neurol. 2009;66:735–741.
   PubMedGoogle Scholar
• Sandroni P, Low PA. Other autonomic neuropathies associated with ganglionic antibody. Auton Neurosci. 2009;146:13–17.
   PubMed Web of Science ®Google Scholar
• Iodice V, Kimpinski K, Vernino S, et al. Efficacy of immunotherapy in seropositive and seronegative putative autoimmune autonomic ganglionopathy. Neurology. 2009;72:2002–2008.
   PubMed Web of Science ®Google Scholar
• Golden EP, Bryarly MA, Vernino S. Seronegative autoimmune autonomic neuropathy: a distinct clinical entity. Clin Auton Res. 2018 Feb;28(1):115–123.
   PubMed Web of Science ®Google Scholar
• Benarroch EE. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc. 2012;87:1214–1225.
   PubMed Web of Science ®Google Scholar
• Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology. 1993;43:132–137.
   PubMed Web of Science ®Google Scholar
• Loavenbruck A, Iturrino J, Singer W, et al. Disturbances of gastrointestinal transit and autonomic functions in postural orthostatic tachycardia syndrome. Neurogastroenterol Motil. 2015;27:92–98.
   PubMed Web of Science ®Google Scholar
• Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus. 2015;24:1364–1369.
   PubMed Web of Science ®Google Scholar
• Dahan S, Tomljenovic L, Shoenfeld Y. Postural orthostatic tachycardia syndrome (POTS) - a novel member of the autoimmune family. Lupus. 2016;25:339–342.
   PubMed Web of Science ®Google Scholar
• Wang XL, Chai Q, Charlesworth MC, et al. Autoimmunoreactive IgGs from patients with postural orthostatic tachycardia syndrome. Proteomics Clin Appl. 2012;6:615–625.
   PubMed Web of Science ®Google Scholar
• Wang XL, Ling TY, Charlesworth MC, et al. Autoimmunoreactive IgGs against cardiac lipid raft-associated proteins in patients with postural orthostatic tachycardia syndrome. Transl Res. 2013;162:34–44.
   PubMed Web of Science ®Google Scholar
• Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3:e000755.
   PubMed Web of Science ®Google Scholar
• Wallukat G, Schimuke I. Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases. Semin Immunopathol. 2014;36:351–363.
   PubMed Web of Science ®Google Scholar
• Yu X, Li H, Murphy TA, et al. Type 1 receptor autoantibodies in postural tachycardia syndrome. J Am Heart Assoc. 2018;7:e008351.
   PubMed Web of Science ®Google Scholar
• Fedorowski A, Li H, Yu X, et al. Antiadrenergic autoimmunity in postural tachycardia syndrome. Europace. 2017;19:1211–1219.
   PubMed Web of Science ®Google Scholar
• Ruzieh M, Batizy L, Dasa O, et al. The role of autoantibodies in the syndromes of orthostatic intolerance: a systematic review. Scand Cardiovasc J. 2017;51:243–247.
   PubMed Web of Science ®Google Scholar
• Watari M, Nakane S, Mukaino A, et al. Autoimmune postural orthostatic tachycardia syndrome. Ann Clin Transl Neurol. 2018;5:486–492.
   PubMed Web of Science ®Google Scholar
• Munetsugu T, Fujimoto T, Oshima Y, et al. Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan. J Dermatol. 2017;44:394–400.
   PubMed Web of Science ®Google Scholar
• Asahina M, Sano K, Fujinuma Y, et al. Investigation of antimuscarinic receptor autoantibodies in patients with acquired idiopathicgeneralized anhidrosis. Intern Med. 2013;52:2733–2737.
   PubMed Web of Science ®Google Scholar
• Yoshifuku A, Yoneda K, Sakiyama Y, et al. Case of autoimmune autonomic ganglionopathy manifesting anhidrosis. J Dermatol. 2017;44:1160–1163.
   PubMed Web of Science ®Google Scholar
• Kato K, Namiki T, Yokozeki H. Acquired anhidrosis in a case of autoimmune autonomic ganglionopathy. J Dermatol. 2017;44:e36–e37.
   PubMed Web of Science ®Google Scholar
• Dhamija R, Tan KM, Pittock SJ, et al. Serologic profiles aiding the diagnosis of autoimmune gastrointestinal dysmotility. Clin Gastroenterol Hepatol. 2008;6:988–992.
   PubMed Web of Science ®Google Scholar
• Flanagan EP, Saito YA, Lennon VA, et al. Immunotherapy trial as diagnostic test in evaluating patients with presumed autoimmune gastrointestinal dysmotility. Neurogastroenterol Motil. 2014;26:1285–1297.
   PubMed Web of Science ®Google Scholar
• Verne GN, Sallustio JE, Eaker EY. Anti-myenteric neuronal antibodies in patients with achalasia. A Prospective Study. Dig Dis Sci. 1997;42:307–313.
   PubMed Web of Science ®Google Scholar
• Kraichely RE, Farrugia G, Pittock SJ, et al. Neural autoantibody profile of primary achalasia. Dig Dis Sci. 2010;55:307–311.
   PubMed Web of Science ®Google Scholar
• Hubball AW, Lang B, Souza MA, et al. Voltage-gated potassium channel (K(v) 1) autoantibodies in patients with chagasic gut dysmotility and distribution of K(v) 1 channels in human enteric neuromusculature (autoantibodies in GI dysmotility). Neurogastroenterol Motil. 2012;24:719–728.
   PubMed Web of Science ®Google Scholar
• Goin JC, Sterin-Borda L, Bilder CR, et al. Functional implications of circulating muscarinic cholinergic receptor autoantibodies in chagasic patients with achalasia. Gastroenterology. 1999;117:798–805.
   PubMed Web of Science ®Google Scholar
• Törnblom H, Lang B, Clover L, et al. Autoantibodies in patients with gut motility disorders and enteric neuropathy. Scand J Gastroenterol. 2007;42:1289–1293.
   PubMed Web of Science ®Google Scholar
• Mukaino A, Minami H, Isomoto H, et al. Anti-ganglionic AChR antibodies in Japanese patients with motility disorders. J Gastroenterol. 2018. Epub ahead of print.
   PubMed Web of Science ®Google Scholar
• Goldstein DS, Holmes C, Imrich R. Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: preliminary observations. Auton Neurosci. 2009;146:18–21.
   PubMed Web of Science ®Google Scholar
• Gorson KC, Herrmann DN, Thiagarajan, et al. Non-length dependent small fibre neuropathy/ganglionopathy. J Neurol Neurosurg Psychiatry. 2008;79:163–169.
   PubMed Web of Science ®Google Scholar
• Provitera V, Gibbons CH, Wendelschafer-Crabb G, et al. The role of skin biopsy in differentiating small-fiber neuropathy from ganglionopathy. Eur J Neurol. 2018;25:848–853.
   PubMed Web of Science ®Google Scholar
• Wieland DM, Brown LE, Rogers WL, et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med. 1981;22:22–31.
   PubMed Web of Science ®Google Scholar
• Druschky A, Hilz MJ, Platsch G, et al. Differentiation of Parkinson’s disease and multiple system atrophy in early disease stages by means of I-123-MIBG-SPECT. J Neurol Sci. 2000;175:3–12.
   PubMed Web of Science ®Google Scholar
• Spiegel J, Hellwig D, Farmakis G, et al. Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord. 2007;22:1004–1008.
   PubMed Web of Science ®Google Scholar
• Kimpinski K, Iodice V, Sandroni P, et al. Sudomotor dysfunction in autoimmune autonomic ganglionopathy. Neurology. 2009;73:1501–1506.
   PubMed Web of Science ®Google Scholar
• Manganelli F, Dubbioso R, Nolano M, et al. Autoimmune autonomic ganglionopathy: a possible postganglionic neuropathy. Arch Neurol. 2011;68:504–507.
   PubMedGoogle Scholar
• Maeda Y, Nakane S, Higuchi O, et al. Ganglionic acetylcholine receptor autoantibodies in patients with autoimmune diseases including primary biliary cirrhosis. Mod Rheumatol. 2017;27:664–668.
   PubMed Web of Science ®Google Scholar
• Gibbons CH, Vernino SA, Freeman R. Combined immunomodulatory therapy in autoimmune autonomic ganglionopathy. Arch Neurol. 2008;65:213–217.
   PubMedGoogle Scholar
• Iodice V, Kimpinski K, Vernino S, et al. Immunotherapy for autoimmune autonomic ganglionopathy. Auton Neurosci. 2009;146:22–25.
   PubMed Web of Science ®Google Scholar
• Winston N, Vernino S. Recent advances in autoimmune autonomic ganglionopathy. Curr Opin Neurol. 2010;23:514–518.
   PubMed Web of Science ®Google Scholar
• Imrich R, Vernino S, Eldadah BA, et al. Autoimmune autonomic ganglionopathy: treatment by plasma exchanges and rituximab. Clin Auton Res. 2009;19:259–262.
   PubMed Web of Science ®Google Scholar
• Nishihara H, Koga M, Higuchi O, et al. Combined immunomodulatory therapies resulted in stepwise recovery in autoimmune autonomic ganglionopathy. Clin Exp Neuroimmunol. 2014. DOI:10.1111/cen3.12137.
   Google Scholar
• Low PA, Gilden JL, Freeman R, et al. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. Jama. 1997;277:1046–1051.
   PubMed Web of Science ®Google Scholar
• Kaufmann H, Freeman R, Biaggioni I, et al. Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial. Neurology. 2014;22(83):328–335.
   Google Scholar
• Kuki I, Kawawaki H, Okazaki S, et al. Autoimmune autonomic ganglionopathy in a pediatric patient presenting with acute encephalitis. Brain Dev. 2016;38:605–608.
   PubMed Web of Science ®Google Scholar
• Mori K, Iijima M, Koike H, et al. The wide spectrum of clinical manifestations in Sjögren’s syndrome-associated neuropathy. Brain. 2005;128:2518–2534.
   PubMed Web of Science ®Google Scholar
• Goto H, Matsuo H, Fukudome T, et al. Chronic autonomic neuropathy in a patient with primary Sjögren’s syndrome. J Neurol Neurosurg Psychiatry. 2000;69:135.
   PubMed Web of Science ®Google Scholar
• Amaral TN, Peres FA, Lapa AT, et al. Neurologic involvement in scleroderma: a systematic review. Semin Arthritis Rheum. 2013;43:335–347.
   PubMed Web of Science ®Google Scholar
• Streifler JY, Molad Y. Connective tissue disorders: systemic lupus erythematosus, Sjögren’s syndrome, and scleroderma. Handb Clin Neurol. 2014;119:463–473.
   PubMedGoogle Scholar
• Ramos-Remus C, Duran-Barragan S, Castillo-Ortiz JD. Beyond the joints: neurological involvement in rheumatoid arthritis. Clin Rheumatol. 2012;31:1–12.
   PubMed Web of Science ®Google Scholar
• Stojanovich L, Milovanovich B, de Luka SR, et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjögren syndrome and other autoimmune diseases. Lupus. 2007;16:181–185.
   PubMed Web of Science ®Google Scholar
• Stacher G, Merio R, Budka C, et al. Cardiovascular autonomic function, autoantibodies, and esophageal motor activity in patients with systemic sclerosis and mixed connective tissue disease. J Rheumatol. 2000;27:692–697.
   PubMed Web of Science ®Google Scholar
• Kondo T, Inoue H, Usui T, et al. Autoimmune autonomic ganglionopathy with Sjögren’s syndrome: significance of ganglionic acetylcholine receptor antibody and therapeutic approach. Auton Neurosci. 2009;146:33–35.
   PubMed Web of Science ®Google Scholar
• Vernino S, Cheshire WP, Lennon VA. Myasthenia gravis with autoimmune autonomic neuropathy. Auton Neurosci. 2001;8:187–192.
   Google Scholar
• Peltier AC, Black BK, Raj SR, et al. Coexistent autoimmune autonomic ganglionopathy and myasthenia gravis associated with non-small-cell lung cancer. Muscle Nerve. 2010;41:416–419.
   PubMed Web of Science ®Google Scholar
• Balestra B, Moretti M, Longhi R, et al. Antibodies against neuronal nicotinic receptor subtypes in neurological disorders. J Neuroimmunol. 2000;102:89–97.
   PubMed Web of Science ®Google Scholar
• Nakane S, Higuchi O, Hamada Y, et al. Ganglionic acetylcholine receptor autoantibodies in patients with Guillain-Barré syndrome. J Neuroimmunol. 2016;295–296:54–59.
   PubMed Web of Science ®Google Scholar
• Vernino S, Low PA, Lennon VA. Experimental autoimmune autonomic neuropathy. J Neurophysiol. 2003;90:2053–2059.
   PubMed Web of Science ®Google Scholar
• Vernino S, Ermilov LG, Sha L, et al. Passive transfer of autoimmune autonomic neuropathy to mice. J Neurosci. 2004;24:7037–7042.
   PubMed Web of Science ®Google Scholar
• Low PA, Dyck PJ, Lambert EH, et al. Acute panautonomic neuropathy. Ann Neurol. 1983;13:412–417.
   PubMed Web of Science ®Google Scholar
• Hirayama K. Acute curable pandysautonomia and chronic progressive pandysautonomia. Bull Osaka Med Coll. 1989;35:113–117.
   PubMedGoogle Scholar
• Okada F, Shintomi Y. The central sites of the autonomic nervous system may also be disturbed in some cases with acute pandysautonomia. Arch Neurol. 1990;47:127–128.
   PubMedGoogle Scholar
• Suarez GA, Fealey RD, Camilleri M, et al. Idiopathic autonomic neuropathy: clinical, neurophysiologic, and follow-up studies on 27 patients. Neurology. 1994;44:1675–1682.
   PubMed Web of Science ®Google Scholar
• Yokota T, Hayashi M, Hirashima F, et al. Dysautonomia with acute sensory motor neuropathy. A new classification of acute autonomicneuropathy. Arch Neurol. 1994;51:1022–1031.
   PubMedGoogle Scholar